Exagen (NASDAQ:XGN) Given New $8.00 Price Target at Canaccord Genuity Group
Exagen (NASDAQ:XGN – Free Report) had its price target lifted by Canaccord Genuity Group from $7.00 to $8.00 in a research note published on Tuesday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other equities analysts have also recently issued reports on the stock. William Blair reiterated an “outperform” rating […]
Exagen (NASDAQ:XGN – Free Report) had its price target lifted by Canaccord Genuity Group from $7.00 to $8.00 in a research note published on Tuesday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other equities analysts have also recently issued reports on the stock. William Blair reiterated an “outperform” rating […]
